Presented at 2025 Cancer Conference: This Banned Plant Extract Erases Suspicious Spots Without Surgery

designed to support skin repair and reduce the appearance of dark spots, blemishes, and discoloration

Scientific References:

logo-item
  • 1. REPYR-SC1: Hemp extract exhibits potent inhibition of squamous cell carcinoma Costoya J., Daunert S.S., Deo S.K., Jimenez J.J. (2025). Proceedings of the AACR Annual Meeting 2025; Apr 25–30; Chicago, IL. Cancer Res 2025; 85(8 Suppl 1): Abstract nr 614.
  • 2. Cannabinoids demonstrate pre-clinical efficacy in cancer models This study shows REPYR-SC1, a novel hemp extract, significantly reduces proliferation in SCC-15 cancer cells and immune cells in vitro.
  • 3. REPYR-SC1 selectively inhibits SCC-15 cells while minimally affecting non-cancerous HEKa cells At 1 and 5 μL/mL, REPYR-SC1 caused 100% inhibition of SCC-15 proliferation; HEKa inhibition remained under 25%.
  • 4. Immunomodulatory potential of cannabinoids supported by T lymphocyte suppression CTLL-2 cells showed complete inhibition at 48 hours with REPYR-SC1 treatment, indicating immune regulation potential.
Cancer Research